PAX5 and acute lymphoblastic leukemia: 86 genes identified as targeted by PAX5-binding in NALM6 cells and downregulated in PAX5 mutated primary B-ALL were found to be more PAX5-responsive than PAX5 unbound or bound but not downregulated in primary B-ALL (S8E Fig).